🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It’s an exciting time at Affinivax and we are focused on the steadfast growth and opportunity within our Manufacturing department. Check out these open roles! affinivax.com/careers/ #WereHiring #SimplePowerfulVaccines

Happy #Juneteenth2022! We take part in honoring this shared history which commemorates the anniversary of the news of freedom reaching enslaved Black Americans. We reflect on its significance and take stock of where we are still in the fight for equality. boston.gov/departments/sm…

Affinivax Presents Data for Enhanced Protection Against Serotype 3 in Next-Generation Pneumococcal Vaccine at the 12th International Symposium on Pneumococci and Pneumococcal Diseases affinivax.com/affinivax-pres…

At #ISPPD12, our poster presentation highlights the possibilities of engineering next generation pneumococcal vaccines. #MAPSnextgenvaccines affinivax.com/affinivax-pres…

#ISPPD12 #MAPSnextgenvaccines affinivax.com/affinivax-pres…

We are delighted to share this publication in the journal Vaccine, detailing results from the Phase 2 clinical trial of our lead novel vaccine candidate targeting Streptococcus pneumoniae, which was developed using our proprietary MAPS™ platform. sciencedirect.com/science/articl…

Happy #PrideMonth! We celebrate Pride on this anniversary of the Stonewall Riots by reflecting on LGBTQIA+ history and striving towards greater visibility and equality. Support this community and the #NextGen Leaders here: pointfoundation.org/donate/ #PrideDay

Looking forward to helping UCDavisMedSchool UC Davis Health achieve greater, coordinated global collaboration, along with our other great schools UC Davis Global Affairs UC Davis Veterinary Medicine Food & Ag, UCDavis UC Davis Public Health Sciences Education Programs and so many more! So much need for coordinated global efforts and health!

We're pleased to share the publication of data in the journal “Vaccines.” The article highlights foundational viral vaccine POC for our MAPS™ vaccine technology platform. mdpi.com/2076-393X/10/7…

Targeted Transcriptomic Screen of Pneumococcal Genes Expressed during Murine and Human Infection | Infection and Immunity journals.asm.org/doi/10.1128/ia…

What parents should know about the #monkeypox. Our Dr. Rick Malley Rick Malley answers your questions on Good Morning America. gma.abc/3oP7SWP

New post on competing view of obesity cause and effect Medium #CarbInsulinModel davidludwigmd.medium.com/when-scientifi…

#AheadTogether "We are very pleased to have found the ideal home within GSK..." GSK x Affinivax

Yesterday we announced the completion of the acquisition of Affinivax – including access to the exciting MAPS technology. Check this out to learn more 👇

Don’t call Donald Trump’s Foreign Policy one of restraint. My latest for National Interest nationalinterest.org/feature/donald…

The History, Challenges + Future Development of Pediatric Pneumococcal Conjugate Vaccines Ep 3 of the Medscape InDiscussion: Pediatric Pneumonia podcast w/ host Dr. Todd Florin + guest Dr. Richard Malley of Boston Children's + Harvard Medical School medscape.com/viewarticle/98…

Back from the 2023 Boston Children's Computational Health Informatics Program @bos_chip faculty retreat. Still absorbing the fantastic discussion and scientific debates. And spectacular keynotes by Stephen Wolfram Ray Kurzweil Rick Malley

9th Edition of Remington & Klein's Infectious Diseases of the Fetus & Newborn Infant to be published June 4th! 42 chapters, 1150 pages, 89 contributors Thanks to my co-editor-in-chief Bonnie Maldonado and our associate editors Elizabeth Barnett, Kathy Edwards, and Rick Malley!

Honored to be on a panel of distinguished academic med leaders/peds ID docs at the PIDS St. Jude meeting where we got to opine on the next 40 yrs of peds ID: consensus was we need more advocacy for the field and kids, and the opportunities are vast #luckytobePedsID